Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, and Chronic Lymphocytic Leukemia Research.
Optimized cytogenetic risk-group stratification of <i>KMT2A</i>-rearranged pediatric acute myeloid leukemia
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Epigenetic regulator genes direct lineage switching in <i>MLL/AF4</i> leukemia
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i>Rearrangements in a Modern Therapy Era: A Retrospective International Study
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
14q32 rearrangements deregulating <i>BCL11B </i>mark a distinct subgroup of T and myeloid immature acute leukemia
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Chronic myeloid leukemia: reminiscences and dreams
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1
The role of the RAS pathway in iAMP21-ALL
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients
Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations
c-MYC is a radiosensitive locus in human breast cells
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome